Targeting KDM4C Prevents Heart Failure after Acute Myocardial Infarction Via Activation of SOS2

Shi HT, Huang ZH, Xu TZ, Sun AJ, Ge JB. New diagnostic and therapeutic strategies for myocardial infarction via nanomaterials. EBioMedicine. 2022;78:103968.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Frantz S, Hundertmark MJ, Schulz-Menger J, Bengel FM, Bauersachs J. Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies. Eur Heart J. 2022;43(27):2549–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jenca D, Melenovsky V, Stehlik J, et al. Heart failure after myocardial infarction: incidence and predictors. ESC Heart Fail. 2021;8(1):222–37.

Article  PubMed  Google Scholar 

Chen Y, Xue J, Yan X, et al. Identification of crucial genes related to heart failure based on GEO database. BMC Cardiovasc Disord. 2023;23(1):376.

Article  PubMed  PubMed Central  Google Scholar 

Qin W, Cao L, Massey IY. Role of PI3K/Akt signaling pathway in cardiac fibrosis. Mol Cell Biochem. 2021;476(11):4045–59.

Article  CAS  PubMed  Google Scholar 

Zhang Q, Wang L, Wang S, et al. Signaling pathways and targeted therapy for myocardial infarction. Signal Transduct Target Ther. 2022;7(1):78.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baltanas FC, Zarich N, Rojas-Cabaneros JM, Santos E. SOS GEFs in health and disease. Biochim Biophys Acta Rev Cancer. 2020;1874(2):188445.

Article  CAS  PubMed  Google Scholar 

Lissewski C, Chune V, Pantaleoni F, et al. Variants of SOS2 are a rare cause of Noonan syndrome with a particular predisposition for lymphatic complications. Eur J Hum Genet. 2021;29(1):51–60.

Article  CAS  PubMed  Google Scholar 

Baltanas FC, Garcia-Navas R, Santos E. SOS2 Comes to the Fore: Differential Functionalities in Physiology and Pathology. Int J Mol Sci. 2021;22(12):6613.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ameer SS, Hossain MB, Knoll R. Epigenetics and Heart Failure. Int J Mol Sci. 2020;21(23):9010.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen J, Liu Z, Ma L, et al. Targeting Epigenetics and Non-coding RNAs in Myocardial Infarction: From Mechanisms to Therapeutics. Front Genet. 2021;12:780649.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Berry WL, Janknecht R. KDM4/JMJD2 histone demethylases: epigenetic regulators in cancer cells. Cancer Res. 2013;73(10):2936–42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yao L, He F, Zhao Q, et al. Spatial Multiplexed Protein Profiling of Cardiac Ischemia-Reperfusion Injury. Circ Res. 2023;133(1):86–103.

Article  CAS  PubMed  Google Scholar 

Pan HC, Chen YH, Fang WC, Wu VC, Sun CY. Essential Roles of the Histone Demethylase KDM4C in Renal Development and Acute Kidney Injury. Int J Mol Sci. 2022;23(16):9318.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu K, Zhang H, Luan Y, et al. KDM4C promotes mouse hippocampal neural stem cell proliferation through modulating ApoE expression. FASEB J. 2024;38(5):e23511.

Article  CAS  PubMed  Google Scholar 

Shioura KM, Geenen DL, Goldspink PH. Sex-related changes in cardiac function following myocardial infarction in mice. Am J Physiol Regul Integr Comp Physiol. 2008;295(2):R528–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dong X, Wang L, Song G, et al. Physcion Protects Rats Against Cerebral Ischemia-Reperfusion Injury via Inhibition of TLR4/NF-kB Signaling Pathway. Drug Des Devel Ther. 2021;15:277–87.

Article  PubMed  PubMed Central  Google Scholar 

Ong SB, Hernandez-Resendiz S, Crespo-Avilan GE, et al. Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities. Pharmacol Ther. 2018;186:73–87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sheffels E, Sealover NE, Wang C, et al. Oncogenic RAS isoforms show a hierarchical requirement for the guanine nucleotide exchange factor SOS2 to mediate cell transformation. Sci Signal. 2018; 11(546).

Hartman MHT, Groot HE, Leach IM, Karper JC, van der Harst P. Translational overview of cytokine inhibition in acute myocardial infarction and chronic heart failure. Trends Cardiovasc Med. 2018;28(6):369–79.

Article  CAS  PubMed  Google Scholar 

Pan Q, Guo C, Sun C, Fan J, Fang C. Integrative analysis of the transcriptome and targetome identifies the regulatory network of miR-16: an inhibitory role against the activation of hepatic stellate cells. Biomed Mater Eng. 2014;24(6):3863–71.

PubMed  Google Scholar 

Theard PL, Linke AJ, Sealover NE, et al. SOS2 modulates the threshold of EGFR signaling to regulate osimertinib efficacy and resistance in lung adenocarcinoma. Mol Oncol. 2023;18:641.

Article  Google Scholar 

Aleksova A, Janjusevic M, Gagno G, et al. The Role of Exercise-Induced Molecular Processes and Vitamin D in Improving Cardiorespiratory Fitness and Cardiac Rehabilitation in Patients With Heart Failure. Front Physiol. 2021;12:794641.

Article  PubMed  Google Scholar 

Feng L, Li B, Xi Y, Cai M, Tian Z. Aerobic exercise and resistance exercise alleviate skeletal muscle atrophy through IGF-1/IGF-1R-PI3K/Akt pathway in mice with myocardial infarction. Am J Physiol Cell Physiol. 2022;322(2):C164–76.

Article  CAS  PubMed  Google Scholar 

Wang X, Li W, Zhang Y, et al. Calycosin as a Novel PI3K Activator Reduces Inflammation and Fibrosis in Heart Failure Through AKT-IKK/STAT3 Axis. Front Pharmacol. 2022;13:828061.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cao H, Zhao L, Yuan Y, et al. Lipoamide Attenuates Hypertensive Myocardial Hypertrophy Through PI3K/Akt-Mediated Nrf2 Signaling Pathway. J Cardiovasc Transl Res. 2024;17(4):910–22.

Article  PubMed  PubMed Central  Google Scholar 

Wang J, Lin B, Zhang Y, et al. The Regulatory Role of Histone Modification on Gene Expression in the Early Stage of Myocardial Infarction. Front Cardiovasc Med. 2020;7:594325.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu CF, Tang WHW. Epigenetics in Cardiac Hypertrophy and Heart Failure. JACC Basic Transl Sci. 2019;4(8):976–93.

Article  PubMed  PubMed Central  Google Scholar 

Ono T, Kamimura N, Matsuhashi T, et al. The histone 3 lysine 9 methyltransferase inhibitor chaetocin improves prognosis in a rat model of high salt diet-induced heart failure. Sci Rep. 2017;7:39752.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang Y, Chen ZY, Hong YZ, et al. Expression profiles of histone lysine demethylases during cardiomyocyte differentiation of mouse embryonic stem cells. Acta Pharmacol Sin. 2014;35(7):899–906.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Comments (0)

No login
gif